The DOI matches its Crossref record; 281 of the 282 references it cites were found in a registry or an index.
T cell regeneration after immunological injury
Open accessAbstract
Following periods of haematopoietic cell stress, such as after chemotherapy, radiotherapy, infection and transplantation, patient outcomes are linked to the degree of immune reconstitution, specifically of T cells. Delayed or defective recovery of the T cell pool has significant clinical consequences, including prolonged immunosuppression, poor vaccine responses and increased risks of infections and malignancies. Thus, strategies that restore thymic function and enhance T cell reconstitution can provide considerable benefit to individuals whose immune system has been decimated in various settings. In this Review, we focus on the causes and consequences of impaired adaptive immunity and discuss therapeutic strategies that can recover immune function, with a particular emphasis on approaches that can promote a diverse repertoire of T cells through de novo T cell formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since cytoreductive therapy significantly impairs the immune system [37], the potential to induce strong CD8+ T-cell responses is particularly relevant for an antigen-based immunotherapeutic for GBM, where chemotherapy and radiotherapy remain the standard of care, and induced T cells must cross the blood–brain barrier to invade the immunologically “cold” tumour.”
From Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma (2025) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Changes in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Research works printed but not linked: 1
- Calzolari, A. Recherches experimentales sur un rapport probable entre la function du thymus et celle des testicules. Arch. Ital. Biol. 30, 71–77 (1898). This article presents one of the very first observations suggesting a relationship between sex steroids and thymic function.
Cited by
Sorted by citations
Mittelbrunn, M., & Kroemer, G. (2021) · Nature Immunology · doi:10.1038/s41590-021-00927-z · Cited by 702
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 168
Dysregulation of Systemic Immunity in Aging and Dementia
Lutshumba, J., Nikolajczyk, B. S., & Bachstetter, A. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652111 · Cited by 104
Age-related epithelial defects limit thymic function and regeneration
Kousa, A. I., Jahn, L., Zhao, K., Flores, A. E., Acenas, D. D., II, Lederer, E. E., Argyropoulos, K. V., Lemarquis, A. L., Granadier, D., Cooper, K., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01915-9 · Cited by 116
Self-citationTissue-specific immunity for a changing world
Weisberg, S. P., Ural, B. B., & Färber, D. L. (2021) · Cell · doi:10.1016/j.cell.2021.01.042 · Cited by 104
Metadata
- Authors
- Velardi, E., Tsai, J. J., & van den Brink, M. R. M.
- Affiliations
- Bambino Gesù Children's Hospital (IT)
- State University of New York (US)
- Corresponding author
- Velardi, Enrico
- Venue
- Nature Reviews Immunology
- Published
- 2020-10-23
- Volume
- 21
- Issue
- 5
- Pages
- 277-291
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7583557
- OpenAlex
- W3094124272
- Cited by
- 222
- References
- 282
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 44 · 2023: 38 · 2022: 29 · 2021: 24
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center (P01-CA023766, CA008748, P30 CA008748)
- Society of Memorial Sloan Kettering (P30-CA008748)
- Parker Institute for Cancer Immunotherapy
- Seres Therapeutics
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
- National Institutes of Health (1r01hl147584-01a1, 7r01ca228308-07)
- National Institute on Aging (P01AG052359)
- National Heart, Lung, and Blood Institute (HL123340, R01‐HL147584, R01HL123340, CA008748, R01HL125571)
- National Cancer Institute (P01CA023766, R01‐CA228308, CA008748, R01CA228358, P30CA008748)
- National Institute of Allergy and Infectious Diseases (AI124275, U01AI124275)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- T cell reconstitution, immune reconstitution, thymic function, T cell depletion, chemotherapy, radiotherapy, transplantation, infection, adaptive immunity, T cell diversity, immunosuppression, vaccine response
- MeSH terms
- Immunosenescence, Animals, B-Lymphocytes, Graft vs Host Disease, Humans, Immunotherapy, Lymphopenia, Regeneration, Stress, Physiological, T-Lymphocytes, Hematopoietic Stem Cell Transplantation, Models, Immunological, Adaptive Immunity, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
